PM

Prosight Management Portfolio holdings

AUM $410M
This Quarter Return
+6.36%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$410M
AUM Growth
+$410M
Cap. Flow
+$95.4M
Cap. Flow %
23.27%
Top 10 Hldgs %
62.72%
Holding
47
New
9
Increased
19
Reduced
10
Closed
8

Top Buys

1
UNH icon
UnitedHealth
UNH
$34.3M
2
GLPG icon
Galapagos
GLPG
$12.8M
3
FOLD icon
Amicus Therapeutics
FOLD
$12M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
$8.57M
5
CON
Concentra Group Holdings Parent, Inc.
CON
$6.42M

Top Sells

1
SDGR icon
Schrodinger
SDGR
$7.6M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
$7.29M
3
ISRG icon
Intuitive Surgical
ISRG
$6.93M
4
ABCL icon
AbCellera Biologics
ABCL
$6.28M
5
BBIO icon
BridgeBio Pharma
BBIO
$5.93M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GLPG icon
1
Galapagos
GLPG
$2.06B
$49.6M 12.11%
1,773,649
+458,751
+35% +$12.8M
UNH icon
2
UnitedHealth
UNH
$279B
$34.3M 8.37%
+110,000
New +$34.3M
MGTX icon
3
MeiraGTx Holdings
MGTX
$590M
$29.9M 7.29%
4,587,423
+895,877
+24% +$5.84M
ADCT icon
4
ADC Therapeutics
ADCT
$370M
$28.1M 6.84%
10,467,771
+924,767
+10% +$2.48M
BBIO icon
5
BridgeBio Pharma
BBIO
$9.91B
$20.4M 4.98%
472,687
-137,313
-23% -$5.93M
ROIV icon
6
Roivant Sciences
ROIV
$8.6B
$20.4M 4.97%
1,808,539
-17,624
-1% -$199K
FOLD icon
7
Amicus Therapeutics
FOLD
$2.42B
$19.9M 4.86%
3,480,044
+2,100,661
+152% +$12M
JANX icon
8
Janux Therapeutics
JANX
$1.38B
$19.7M 4.81%
853,904
+164,003
+24% +$3.79M
KURA icon
9
Kura Oncology
KURA
$732M
$18.4M 4.48%
3,181,184
+1,102,869
+53% +$6.36M
ZYME icon
10
Zymeworks
ZYME
$1.07B
$16.4M 4.01%
1,309,904
+352,675
+37% +$4.43M
ICLR icon
11
Icon
ICLR
$14B
$14.3M 3.5%
98,558
+38,459
+64% +$5.59M
ARGX icon
12
argenx
ARGX
$44.2B
$12.1M 2.96%
22,000
+8,300
+61% +$4.58M
MIRM icon
13
Mirum Pharmaceuticals
MIRM
$3.75B
$10.2M 2.48%
200,000
-143,326
-42% -$7.29M
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.39B
$10.1M 2.47%
1,079,673
+470,421
+77% +$4.41M
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$8.78M 2.14%
442,056
+43,171
+11% +$858K
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$3.26B
$8.57M 2.09%
+298,123
New +$8.57M
CTMX icon
17
CytomX Therapeutics
CTMX
$350M
$7.98M 1.95%
3,517,113
-412,895
-11% -$937K
IMVT icon
18
Immunovant
IMVT
$2.91B
$7.67M 1.87%
479,400
+119,400
+33% +$1.91M
BHVN icon
19
Biohaven
BHVN
$1.71B
$7.61M 1.85%
539,071
+439,071
+439% +$6.2M
CON
20
Concentra Group Holdings Parent, Inc.
CON
$3.04B
$6.42M 1.57%
+312,105
New +$6.42M
LIVN icon
21
LivaNova
LIVN
$3.09B
$6.3M 1.54%
140,000
+12,700
+10% +$572K
DXCM icon
22
DexCom
DXCM
$30.9B
$6.11M 1.49%
+70,000
New +$6.11M
CDNA icon
23
CareDx
CDNA
$678M
$5.92M 1.44%
302,808
+166,215
+122% +$3.25M
SEM icon
24
Select Medical
SEM
$1.6B
$5.37M 1.31%
+353,820
New +$5.37M
STTK icon
25
Shattuck Labs
STTK
$61.3M
$5.26M 1.28%
6,638,935
– –
1
2